SurModics (SRDX) Stock Rating Lowered by BidaskClub
SurModics (NASDAQ:SRDX) was downgraded by BidaskClub from a “hold” rating to a “sell” rating in a research note issued on Tuesday.
A number of other equities research analysts have also recently commented on the company. Zacks Investment Research cut SurModics from a “hold” rating to a “sell” rating in a research note on Wednesday, November 15th. ValuEngine raised SurModics from a “sell” rating to a “hold” rating in a research note on Friday, September 1st. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and two have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $40.00.
SurModics (SRDX) traded up $0.30 during midday trading on Tuesday, reaching $29.30. The company had a trading volume of 21,100 shares, compared to its average volume of 39,336. SurModics has a fifty-two week low of $21.90 and a fifty-two week high of $34.15. The firm has a market capitalization of $379.86, a PE ratio of 56.86 and a beta of 0.83.
SurModics (NASDAQ:SRDX) last released its earnings results on Wednesday, November 8th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of ($0.01) by $0.19. SurModics had a return on equity of 6.18% and a net margin of 5.37%. The business had revenue of $20.06 million during the quarter, compared to analysts’ expectations of $16.98 million. equities analysts expect that SurModics will post -0.44 EPS for the current year.
Hedge funds have recently bought and sold shares of the company. SG Americas Securities LLC bought a new position in shares of SurModics in the third quarter valued at approximately $116,000. Macquarie Group Ltd. bought a new stake in shares of SurModics in the third quarter valued at $123,000. BNP Paribas Arbitrage SA raised its stake in shares of SurModics by 66.1% in the second quarter. BNP Paribas Arbitrage SA now owns 4,270 shares of the company’s stock valued at $120,000 after buying an additional 1,700 shares during the period. Municipal Employees Retirement System of Michigan raised its stake in shares of SurModics by 59.1% in the third quarter. Municipal Employees Retirement System of Michigan now owns 4,980 shares of the company’s stock valued at $154,000 after buying an additional 1,850 shares during the period. Finally, Condor Capital Management bought a new stake in shares of SurModics in the third quarter valued at $208,000. Institutional investors own 85.64% of the company’s stock.
TRADEMARK VIOLATION WARNING: “SurModics (SRDX) Stock Rating Lowered by BidaskClub” was posted by Daily Political and is the property of of Daily Political. If you are reading this story on another domain, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this story can be read at https://www.dailypolitical.com/2017/12/14/surmodics-srdx-stock-rating-lowered-by-bidaskclub.html.
SurModics Company Profile
Surmodics, Inc is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company’s Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices; international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device.
Receive News & Ratings for SurModics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SurModics and related companies with MarketBeat.com's FREE daily email newsletter.